tiprankstipranks
Trending News
More News >
Protagonist Therapeutics (DE:PGF)
BERLIN:PGF
Advertisement

Protagonist Therapeutics (PGF) Revenue

Compare
1 Followers

Protagonist Therapeutics Revenue

Protagonist Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 204.50M, Increased -2.23%. In the fiscal year ending Dec 31, 2024, Protagonist Therapeutics had annual revenue of 434.43M with 624.05% growth.
Revenue (ttm)
204.50M
Revenue Growth
P/S Ratio
9.87
Revenue/Employee
$3,503,492
Employees
124
Market Cap
$4.29B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
434.43M374.43M+724.06%
Dec 31, 2023
60.00M33.42M+225.73%
Dec 31, 2022
26.58M-776.00K+97.16%
Dec 31, 2021
27.36M-1.27M+95.56%
Dec 31, 2020
28.63M28.40M+12,393.13%
Dec 31, 2019
231.00K-30.69M+0.75%
Dec 31, 2018
30.93M10.86M+154.14%
Dec 31, 2017
20.06M-2,006,300,000.00%
Dec 31, 2016
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis